Authors: Janoir, C Varon, E Kitzis, MD Gutmann, L

Citation: C. Janoir et al., New mutation in ParE in a pneumococcal in vitro mutant resistant to fluoroquinolones, ANTIM AG CH, 45(3), 2001, pp. 952-955

Authors: Varon, E Janoir, C Kitzis, MD Gutmann, L

Citation: E. Varon et al., ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniae, ANTIM AG CH, 43(2), 1999, pp. 302-306

Authors: Janoir, C Podglajen, I Kitzis, MD Poyart, C Gutmann, L

Citation: C. Janoir et al., In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S-mitis, J INFEC DIS, 180(2), 1999, pp. 555-558

Authors: Guibert, J Kitzis, MD Acar, JF

Citation: J. Guibert et al., Antibacterial activity of ofloxacin in urine during four days after a single oral 400-mg dose, PATH BIOL, 46(8), 1998, pp. 656-660

Authors: Garrec, F Bensousan, T Kitzis, MD Leclercq, B

Citation: F. Garrec et al., Cefatzidime overdose in acute renal failure: evolution of ceftazidine cerebrospinal fluid concentration, THERAPIE, 53(5), 1998, pp. 516-517